Rezzayo antifungal okayed as Candida auris rings alarm bells
Drug is first new echinocandin to be approved for marketing in the US in more than a decade.
Sanofi, Regeneron’s wager on Dupixent in COPD pays off
Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.
Challenges and opportunities with plasma-derived therapies
This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.
How technology enables more dynamic brand planning
Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help bring brand planning and strategy development into the digital age.
Exploring the potential of the metaverse in healthcare
Immersive experiences could be impactful and valuable to life sciences and healthcare.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Cell & Gene Therapy Summit 2023
Enabling market access, policy, and delivery 24th-25th April 2023, Brussels
Maximizing Insights At Congresses
In terms of gathering medical insights, congresses are unique for several reasons.
The Challenge Of Finding KOLs For Innovative Therapies
You have a truly innovative medicine with a unique proposition in an area with a clear unmet need
Social Health and Cancer as a Chronic Condition
Data demonstrates the critical role of social health for people living with and beyond cancer
Newel Health begins next phase of development of Soturi
Newel Health's Soturi, a DTx solution for Parkinson’s Disease, begins next phase.